CORDARO, Marika
 Distribuzione geografica
Continente #
EU - Europa 3.874
NA - Nord America 3.657
AS - Asia 1.336
SA - Sud America 11
OC - Oceania 6
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.888
Nazione #
US - Stati Uniti d'America 3.652
IE - Irlanda 1.236
IT - Italia 876
SE - Svezia 868
CN - Cina 646
PL - Polonia 546
SG - Singapore 482
DE - Germania 105
IN - India 78
VN - Vietnam 60
FI - Finlandia 57
ID - Indonesia 47
AT - Austria 37
BE - Belgio 37
GB - Regno Unito 32
CZ - Repubblica Ceca 17
FR - Francia 16
NL - Olanda 16
RU - Federazione Russa 11
UA - Ucraina 11
BR - Brasile 7
HK - Hong Kong 6
CA - Canada 5
MY - Malesia 5
AU - Australia 4
CL - Cile 3
BA - Bosnia-Erzegovina 2
NZ - Nuova Zelanda 2
PH - Filippine 2
SC - Seychelles 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BG - Bulgaria 1
EE - Estonia 1
EU - Europa 1
IL - Israele 1
JP - Giappone 1
KR - Corea 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
MA - Marocco 1
MK - Macedonia 1
NO - Norvegia 1
PK - Pakistan 1
PT - Portogallo 1
RO - Romania 1
TW - Taiwan 1
Totale 8.888
Città #
Dublin 1.236
Chandler 853
Nyköping 705
Warsaw 546
Singapore 396
Messina 336
Princeton 239
Beijing 221
Ashburn 179
Medford 173
Ann Arbor 161
Des Moines 136
Jacksonville 125
Dearborn 119
New York 73
Boardman 71
Dong Ket 59
Cologne 52
Houston 50
Jinan 48
Cambridge 47
Jakarta 47
Shenyang 46
San Mateo 45
Wilmington 43
Pune 40
Brussels 37
Vienna 36
Milan 35
Los Angeles 33
Nanjing 32
Rome 32
Hyderabad 27
Tianjin 26
Hebei 23
Munich 23
Zhengzhou 23
Catania 22
Guangzhou 21
Ningbo 21
Palermo 20
Francofonte 19
Nanchang 19
Falls Church 18
Hangzhou 18
Helsinki 18
Brno 17
Haikou 17
Lancaster 17
Pace 17
Seattle 16
Taizhou 16
Lanzhou 15
Fuzhou 14
Naples 11
Fairfield 10
Misterbianco 10
Acireale 8
Berlin 8
Florence 8
Modica 8
Bremen 7
Changsha 7
Santa Clara 7
Borghetto Santo Spirito 6
Brescia 6
Brooklyn 6
Jiaxing 6
London 6
Norwalk 6
Bologna 5
Carini 5
Lappeenranta 5
Alessandria 4
Cagliari 4
Floridia 4
Fort Worth 4
Hefei 4
Hong Kong 4
Napoli 4
Noto 4
Redwood City 4
Reggio Calabria 4
Sannicandro Di Bari 4
Shah Alam 4
Taiyuan 4
Tappahannock 4
Washington 4
Xi'an 4
Acate 3
Bari 3
Bronte 3
Caserta 3
Corigliano Calabro 3
Cusano Milanino 3
Dalian 3
Dehradun 3
Ferrara di Monte Baldo 3
Genoa 3
Laurel 3
Totale 6.910
Nome #
The role of mTOR signaling pathway in Brain and Spinal Cord Injury 273
The association of adelmidrol with sodium hyaluronate displays beneficial properties against bladder changes following spinal cord injury in mice 120
N-Palmitoylethanolamine-oxazoline (PEA-OXA): A new therapeutic strategy to reduce neuroinflammation, oxidative stress associated to vascular dementia in an experimental model of repeated bilateral common carotid arteries occlusion 117
Adelmidrol, a palmitoylethanolamide analogue, as a new pharmacological treatment for the management of inflammatory bowel disease 96
Erratum to: Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain 95
The Neuroprotective Effect of Dimethyl Fumarate in an MPTP-Mouse Model of Parkinson's Disease: Involvement of Reactive Oxygen Species/Nuclear Factor-κB/Nuclear Transcription Factor Related to NF-E2 95
Adaptation to oxidative stress at cellular and tissue level 94
The neuroprotective effects of co-ultraPEALut in a mouse model of spinal cord injury 92
Synthesis of bismuth nanoparticles for biomedical applications 90
B-Cell Depletion with CD20 Antibodies as New Approach in the Treatment of Inflammatory and Immunological Events Associated with Spinal Cord Injury 89
Dimethyl fumarate reduces inflammatory responses in experimental colitis 86
Correction to: Potential eye drop based on a calix[4]arene nanoassembly for curcumin delivery: Enhanced drug solubility, stability, and anti-inflammatory effect (Molecular Pharmaceutics (2017) 14:5 (1610-1622) DOI: 10.1021/acs.molpharmaceut.6b01066) 84
Anti-inflammatory and Antioxidant Effects of Flavonoid-Rich Fraction of Bergamot Juice (BJe) in a Mouse Model of Intestinal Ischemia/Reperfusion Injury 81
Adelmidrol, a palmitoylethanolamide analogue, as a new pharmacological treatment for the management of acute and chronic inflammation 80
The anti-inflammatory and antioxidant potential of pistachios (Pistacia vera L.) in vitro and in vivo 80
2-Pentadecyl-2-oxazoline, the oxazoline of PEA, modulates carrageenan-induced acute inflammation 80
Beneficial Effects of Co-Ultramicronized Palmitoylethanolamide/Luteolin in a Mouse Model of Autism and in a Case Report of Autism 80
Role of natural antioxidants and potential use of bergamot in treating rheumatoid arthritis 79
Liver X receptors activation, through TO901317 binding, reduces neuroinflammation in Parkinson's disease 77
Adelmidrol + sodium hyaluronate in IC/BPS or conditions associated to chronic urothelial inflammation. A translational study 76
The Neuroprotective Effects of Micronized PEA (PEA-m) Formulation on Diabetic Neuropathy in Mice 76
Fumaric Acid Esters Attenuate Secondary Degeneration and Promote Functional Recovery Following Experimental Spinal Cord Injury 76
Vascular dementia and aliamides: A new approach for the future 75
Adelmidrol, in combination with hyaluronic acid, displays increased anti-inflammatory and analgesic effects against monosodium iodoacetate-induced osteoarthritis in rats 74
2-Pentadecyl-2-Oxazoline reduces neuroinflammatory environment in the MPTP model of Parkinson Disease 74
The Association of Palmitoylethanolamide with Luteolin Decreases Autophagy in Spinal Cord Injury 74
KU0063794, a Dual mTORC1 and mTORC2 Inhibitor, Reduces Neural Tissue Damage and Locomotor Impairment After Spinal Cord Injury in Mice 72
Adelmidrol: A New Promising Antioxidant and Anti-Inflammatory Therapeutic Tool in Pulmonary Fibrosis 71
Co-ultramicronized Palmitoylethanolamide/Luteolin in the Treatment of Cerebral Ischemia: from Rodent to Man 70
N-palmitoylethanolamide Prevents Parkinsonian Phenotypes in Aged Mice 69
Co-ultramicronized palmitoylethanolamide/luteolin promotes neuronal regeneration after spinal cord injury 68
Anti-inflammatory and neuroprotective effects of co-ultraPEALut in a mouse model of vascular dementia 66
2-Pentadecyl-2-Oxazoline reduces neuroinflammatory environment in the MPTP model of Parkinson Disease 65
Ultramicronized palmitoylethanolamide (PEA-um(®)) in the treatment of idiopathic pulmonary fibrosis 63
A new co-micronized composite containing palmitoylethanolamide and polydatin shows superior oral efficacy compared to their association in a rat paw model of carrageenan-induced inflammation 63
Absence of formyl peptide receptor 1 causes endometriotic lesion regression in a mouse model of surgically-induced endometriosis 63
Gut-Brain Actions Underlying Comorbid  Neuropsychiatric Disturb Associated with Inflammatory Bowel Disease 63
Co-Ultra PEALut Enhances Endogenous Repair Response Following Moderate Traumatic Brain Injury 63
The Association of Palmitoylethanolamide with Luteolin Decreases Neuroinflammation and Stimulates Autophagy in Parkinson's Disease Model 62
Fumaric Acid Esters Attenuate Secondary Degeneration and Promote Functional Recovery Following Experimental Spinal Cord Injury 62
The antioxidative property of melatonin against brain ischemia 60
Gut–Brain Actions Underlying Comorbid Neuropsychiatric Disturb Associated With Inflammatory Bowel Disease 60
N-Palmitoylethanolamide-oxazoline Treatments Protects Against Neuroinflammatory Injury Induced by Transient Middle Cerebral Artery Occlusion in Diabetic Rats 59
N-acetyl-L-cysteine reduces Leishmania amazonensis-induced inflammation in BALB/c mice 59
Formyl peptide receptor 1 signalling promotes experimental colitis in mice 59
2-Pentadecyl-2-Oxazoline Reduces Neuroinflammatory Environment in the MPTP Model of Parkinson Disease 58
2-pentadecyl-2-oxazoline: Identification in coffee, synthesis and activity in a rat model of carrageenan-induced hindpaw inflammation 58
Atrazine Inhalation Worsen Pulmonary Fibrosis Regulating the Nuclear Factor-Erythroid 2-Related Factor (Nrf2) Pathways Inducing Brain Comorbidities 58
B Cell depletion with CD20 antibodies as new approach in the treatment of inflammatory and immunological events associated with spinal cord 57
Neuroprotective Effects of Temsirolimus in Animal Models of Parkinson's Disease 56
Autophagy and Liver Diseases 56
Protective Effects of Ultramicronized Palmitoylethanolamide (PEA-UM®) in Myocardial Ischaemia and Reperfusion Injury in Vivo 55
Effects of a co-micronized composite containing palmitoylethanolamide and polydatin in an experimental model of benign prostatic hyperplasia 55
Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain 54
Protective effect of polyphenols in an inflammatory process associated with experimental pulmonary fibrosis in mice 54
B Cell-Targeted Therapy with Anti-CD20 Monoclonal Antibody Reduced Secondary Tissue Damage and Enhanced Behavioural Recovery Following Experimental Spinal Cord Injury in Mice 54
Formyl Peptide Receptor 1 Signaling in Acute Inflammation and Neural Differentiation Induced by Traumatic Brain Injury 54
KU0063794, a dual mTORC1 and mTORC2 inhibitor, reduces neural tissue damage and locomotor impairment after spinal cord injury in mice 53
The protective effects of pre-and post-administration of micronized palmitoylethanolamide formulation on postoperative pain in rats 52
Co-ultraPEALut: Role in Preclinical and Clinical Delirium Manifestations 51
Aflatoxin b1 toxicity in zebrafish larva (Danio rerio): Protective role of hericium erinaceus 51
Preventive and therapeutic effects of thymosin β4 N-terminal fragment Ac-SDKP in the bleomycin model of pulmonary fibrosis 50
null 50
Inhibition of Poly(ADP-Ribose) Polymerase Activity Modulates Autophagy Induced by Experimental Spinal Cord Trauma 49
N-Palmitoylethanolamide-Oxazoline Protects against Middle Cerebral Artery Occlusion Injury in Diabetic Rats by Regulating the SIRT1 Pathway 49
The antioxidant and anti-inflammatory properties of Anacardium occidentale l. Cashew nuts in a mouse model of colitis 49
Effects of hydroxytyrosol against lipopolysaccharide-induced inflammation and oxidative stress in bovine mammary epithelial cells: a natural therapeutic tool for bovine mastitis 49
Safety and efficacy of a new micronized formulation of the ALIAmide palmitoylglucosamine in preclinical models of inflammation and osteoarthritis pain 48
An update of palmitoylethanolamide and luteolin effects in preclinical and clinical studies of neuroinflammatory events 48
Assessment of 2-Pentadecyl-2-oxazoline Role on Lipopolysaccharide-Induced Inflammation on Early Stage Development of Zebrafish (Danio rerio) 48
Açai Berry Administration Promotes Wound Healing through Wnt/β-Catenin Pathway 47
Effect of cannabidiol (CBD) on canine inflammatory response: an ex vivo study on LPS stimulated whole blood 47
Effects of a new compound containing Palmitoylethanolamide and Baicalein in myocardial ischaemia/reperfusion injury in vivo 46
Effect of PEA-OXA on neuropathic pain and functional recovery after sciatic nerve crush 46
Neuroprotection by association of palmitoylethanolamide with luteolin in experimental alzheimer’s disease models: the control of neuroinflammation 46
Biochemical Evaluation of the Antioxidant Effects of Hydroxytyrosol on Pancreatitis-Associated Gut Injury 46
Protective effects of Colomast®, A New Formulation of Adelmidrol and Sodium Hyaluronate, in A Mouse Model of Acute Restraint Stress 46
Micronized palmitoylethanolamide (PEA-m): a new pharmacological strategy to prevent neurodegenerative disease associated to the old age 45
Adelmidrol, a palmitoylethanolamide analogue, as a new pharmacological treatment for the management of inflammatory bowel disease 45
Impact of acute inflammation on Band 3 protein anion exchange capability in human erythrocytes 45
Protective effect of hydroxytyrosol on LPS-induced inflammation and oxidative stress in bovine endometrial epithelial cell line 45
Anti-inflammatory and neuroprotective effects of co-ultraPEALut in a mouse model of vascular dementia 45
RUOLO DELL’AUTOFAGIA NELLA NEUROINFIAMMAZIONE ASSOCIATA A LESIONI SPINALI 44
Traumatic Brain Injury Leads to Development of Parkinson's Disease in Mice 44
Protective effect of a new hyaluronic acid -carnosine conjugate on the modulation of the inflammatory response in mice subjected to collagen-induced arthritis 44
Atrazine inhalation causes neuroinflammation, apoptosis and accelerating brain aging 44
Effects of different natural extracts in an experimental model of benign prostatic hyperplasia (BPH) 43
Topical application of adelmidrol + trans-traumatic acid enhances skin wound healing in a streptozotocin-induced diabetic mouse model 43
The neuroprotective effects of micronized PEA (PEA-m) formulation on diabetic peripheral neuropathy in mice 43
Melatonin plus folic acid treatment ameliorates reserpine-induced fibromyalgia: An evaluation of pain, oxidative stress, and inflammation 43
PPAR-α Modulates the Anti-Inflammatory Effect of Melatonin in the Secondary Events of Spinal Cord Injury 42
N-Palmitoylethanolamine-Oxazoline as a New Therapeutic Strategy to Control Neuroinflammation: Neuroprotective Effects in Experimental Models of Spinal Cord and Brain Injury 42
Therapeutic potential of dinitrobenzene sulfonic acid (DNBS)-induced colitis in mice by targeting IL-1beta and IL-18 42
Oral ultramicronized palmitoylethanolamide: Plasma and tissue levels and spinal anti-hyperalgesic effect 42
Metallic nanoparticles generation by repetitive pulsed laser for applications in Bio-Medicine 42
FeTTPs treatment reduces secondary injury associated in a mouse model of traumatic brain injury 42
The protective effect of new carnosine-hyaluronic acid conjugate on the inflammation and cartilage degradation in the experimental model of osteoarthritis 42
Role of Etanercept and Infliximab on Nociceptive Changes Induced by the Experimental Model of Fibromyalgia 41
Environmental Risk Assessment of Oxaliplatin Exposure on Early Life Stages of Zebrafish (Danio rerio) 41
Co-ultramicronized Palmitoylethanolamide/Luteolin in the Treatment of Cerebral Ischemia: from Rodent to Man 41
Totale 6.260
Categoria #
all - tutte 46.192
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.192


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020682 0 0 0 0 13 134 68 50 40 216 111 50
2020/20211.368 58 56 282 80 187 33 83 157 215 133 13 71
2021/20221.327 25 95 44 59 79 29 121 40 30 82 154 569
2022/20233.618 298 323 166 254 259 315 54 210 1.551 32 112 44
2023/20241.030 92 152 62 80 82 188 77 76 9 49 18 145
2024/2025880 90 88 136 345 221 0 0 0 0 0 0 0
Totale 9.494